- The stock price of PharmaCyte Biotech Inc PMCB is trading higher during premarket today.
- Investors are expecting a major announcement from the company today.
- PharmaCyte Biotech will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually today.
- "We are extremely honored to present at H.C. Wainwright's 23rd Annual Global Investment Conference. PharmaCyte is forever grateful to H.C. Wainwright for bringing institutional investors to our door so that we could present our story in two separate capital raises that generated about $90 million," said CEO Kenneth L. Waggoner.
- Price Action: PMCB stock is up 9.94% at $3.76 during the premarket session on the last check Thursday.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...